Recent Advances in Nanomaterials for Asthma Treatment

Int J Mol Sci. 2022 Nov 20;23(22):14427. doi: 10.3390/ijms232214427.


Asthma is a chronic airway inflammatory disease with complex mechanisms, and these patients often encounter difficulties in their treatment course due to the heterogeneity of the disease. Currently, clinical treatments for asthma are mainly based on glucocorticoid-based combination drug therapy; however, glucocorticoid resistance and multiple side effects, as well as the occurrence of poor drug delivery, require the development of more promising treatments. Nanotechnology is an emerging technology that has been extensively researched in the medical field. Several studies have shown that drug delivery systems could significantly improve the targeting, reduce toxicity and improve the bioavailability of drugs. The use of multiple nanoparticle delivery strategies could improve the therapeutic efficacy of drugs compared to traditional delivery methods. Herein, the authors presented the mechanisms of asthma development and current therapeutic methods. Furthermore, the design and synthesis of different types of nanomaterials and micromaterials for asthma therapy are reviewed, including polymetric nanomaterials, solid lipid nanomaterials, cell membranes-based nanomaterials, and metal nanomaterials. Finally, the challenges and future perspectives of these nanomaterials are discussed to provide guidance for further research directions and hopefully promote the clinical application of nanotherapeutics in asthma treatment.

Keywords: asthma; biomedical polymers; drug delivery; nanomaterials; nanoparticles.

Publication types

  • Review

MeSH terms

  • Asthma* / drug therapy
  • Humans
  • Nanostructures* / therapeutic use
  • Pulmonary Disease, Chronic Obstructive*

Supplementary concepts

  • Pulmonary Disease, Chronic Obstructive, Severe Early-Onset